Ironwood Pharmaceuticals | IRWD - Net Income



Ironwood Pharmaceuticals reported $3.19M in Net Income for its fiscal quarter ending in December of 2024.


Net Income Change Date
Acadia Pharmaceuticals USD 26.67M 7.68M Jun/2025
Agios Pharmaceuticals USD -112020000 22.73M Jun/2025
Almirall EUR 26.58M 4.98M Jun/2025
Alnylam Pharmaceuticals USD -66277000 8.8M Jun/2025
Amarin USD -15697000 32.92M Mar/2025
Ardelyx USD -19080000 23.72M Jun/2025
Astellas Pharma JPY 68.42B 6.47B Jun/2025
AstraZeneca USD 2.45B 466M Jun/2025
Charles River Laboratories USD 52.33M 26.86M Jun/2025
Exact Sciences USD -1185000 100.03M Jun/2025
Halozyme Therapeutics USD 165.16M 47.06M Jun/2025
Incyte USD 405M 246.8M Jun/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
MacroGenics USD -36250000 20.83M Jun/2025
Moderna USD -825000000 146M Jun/2025
Myriad Genetics USD -100000 42.4M Mar/2025
Pacira USD -4847000 9.66M Jun/2025
PTC Therapeutics USD -64849000 931.41M Jun/2025
Sarepta Therapeutics USD 196.89M 644.4M Jun/2025
Takeda JPY 124.24B 227.4B Jun/2025
Ultragenyx Pharmaceutical USD -114951000 36.13M Jun/2025